Latest News of APG
Does APi Group (APG) Have a Clear Path To Drive Organic Growth?
SouthernSun Asset Management's Q3 2024 investor letter showcased the success of its SMID Cap Strategy, outperforming indexes. APi Group Corporation (NYSE:APG) was highlighted as a top pick with impres...
An Intrinsic Calculation For APG|SGA SA (VTX:APGN) Suggests It's 39% Undervalued
APG|SGA's stock may not be reflecting its true value, as competitors trade at a smaller discount. Using a two-stage DCF model, future cash flows are estimated and discounted to present value to determ...
Is APi Group Corporation (APG) the Most Undervalued Industrial Stock to Buy According to Analysts?
The article discusses the industrial sector's growth potential and focuses on APi Group Corporation (NYSE:APG) as one of the undervalued stocks. APG expects positive margins from acquisitions and targ...
-
Insider Sale: CFO Jane Henderson Sells 6,000 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 2 months agoJane Henderson, CFO of Apogee Therapeutics Inc, sold 6,000 shares at $48.26 each on August 23, 2024. The company focuses on developing therapies for diseases with unmet medical needs. Henderson now ho...
-
Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoApogee Therapeutics, Inc. is a biotechnology company focusing on developing biologics for conditions like atopic dermatitis, asthma, and COPD. Their primary products are extended half-life monoclonal ...
-
Insider Sale: Carl Dambkowski Sells 7,335 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 3 months agoApogee Therapeutics Inc focuses on developing innovative treatments for medical conditions. An insider recently sold shares worth $298,464.45, adding to a trend of insider selling. Investors should co...
-
Apogee Therapeutics Inc (APGE) CEO Michael Henderson Sells 40,000 Shares
By Yahoo! Finance | 3 months agoApogee Therapeutics Inc CEO, Michael Henderson, sold 40,000 shares at $40.62 each, totaling $1.62 million. With 1,434,487 shares left, the company focuses on innovative therapies....
-
Should You Hold APi Group (APG)?
By Yahoo! Finance | 3 months agoGreystone Capital Management's Q2 2024 investor letter showcased returns ranging from +4.3 to +7.1%, with a median account return of +6.0%. The firm's strategy focuses on small companies, unlike major...
-
What Makes APi Group (APG) a Worthy Investment?
By Yahoo! Finance | 3 months agoLaughing Water Capital's Q2 2024 investor letter discusses a 2.5% return for Class A interests, focusing on hidden market corners. Highlighted stock, APi Group Corporation (NYSE:APG), saw a 28.99% gai...
-
SAP SE (SAPGF) Stock Price, News, Quote & History
By Yahoo! Finance | 3 months agoSAP SE is a global provider of applications, technology, and services, offering a range of solutions including SAP S/4HANA, SAP SuccessFactors, spend management solutions, customer experience solution...
-
Autonomous AI workers that talk to each other will arrive in 2025, Capgemini predicts
By CNBC | 3 months agoBy 2025, Capgemini predicts that artificial intelligence-powered agents will collaborate in a multi-agent AI system to solve tasks collectively. These agents function independently and execute tasks w...
-
SSE and APG progress on 2GW Netherlands offshore wind project
By Yahoo! Finance | 4 months agoSSE and APG are developing the 2GW IJmuiden Ver Alpha offshore wind project in the Netherlands to supply 7% of the country's electricity needs....
-
Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 4 months agoOn July 5, 2024, Apogee Therapeutics Inc's CEO sold 15,000 shares, now owning 1,474,487 shares. The company focuses on autoimmune disease treatments. Valued at $2.143 billion, recent insider transacti...
-
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
By Yahoo! Finance | 4 months agoOn July 3, 2024, Carl Dambkowski, CMO of Apogee Therapeutics Inc (NASDAQ:APGE), sold 5,995 shares. The company focuses on developing medical treatments....
-
Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History
By Yahoo! Finance | 4 months agoApogee Therapeutics appoints Dr. Lisa Bollinger to its board of directors, expanding expertise in biotechnology and immunology. Dr. Bollinger brings valuable experience in regulatory affairs to the cl...